Fast-Acting Sub-Perception Therapy Spinal Cord Stimulation Reduces Back Pain
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 6, 2024 -- Patients with chronic pain treated with the novel Fast-Acting Sub-Perception Therapy (FAST) spinal cord stimulation (SCS) systems may achieve significant and durable pain relief for up to 12 months of follow-up, according to a study presented at the 23rd Annual Pain Medicine Meeting, a meeting of the American Society of Regional Anesthesia and Pain Medicine, held from Nov. 21 to 23 in Las Vegas.
Magdalena Anitescu, M.D., Ph.D., from the University of Chicago, and colleagues evaluated the effectiveness of FAST and additional SCS therapy options for chronic pain. The analysis included 12-month follow-up data for patients implanted with SCS systems (WaveWriter Systems) for chronic pain.
The researchers found that the primary end point of a ≥50 percent reduction in targeted pain with no increase in average daily opioid medications at three months was achieved by 16 of 20 patients. Treatment responder rates of 81, 84, and 90 percent were achieved at three (52 patients), six (38 patients), and 12 months (30 patients) of follow-up. At a mean onset duration of 2.6 minutes, ≥50 percent pain relief was achieved. A mean 5-point reduction in the verbal rating scale low back pain score was achieved at 12 months. An additional 28-point mean improvement in the Oswestry Disability Index score at 12 months was seen. At all time points, consistently high levels of patient satisfaction were observed (>84 percent reporting much or very much improved).
"These outcomes are consistent with real-world observational studies in the United States of America and European Union," the authors write.
Several authors disclosed ties to Boston Scientific.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Discontinuation of Medical Cannabis Common in Musculoskeletal Pain
TUESDAY, Aug. 26, 2025 -- A number of patients with musculoskeletal pain discontinue medical cannabis (MC) within one year, with many discontinuing within the first three months...
Cognitive Functional Therapy Effective for Chronic Low Back Pain at Three Years
WEDNESDAY, Aug. 6, 2025 -- Cognitive functional therapy (CFT), with or without biofeedback, is more effective than usual care for treating patients with chronic disabling low back...
Remote CBT-Based Therapy Yields Modest Improvements in Chronic Pain
MONDAY, July 28, 2025 -- Remote-scalable cognitive behavioral therapy (CBT)-based chronic pain (CP) treatments yield modest improvements in high-impact chronic pain compared with...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.